BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 28, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MiStent: Phase II started

Micell began the single-blind, international Phase II DESSOLVE II trial to compare MiStent sirolimus-eluting coronary stent vs. Endeavor zotarolimus-eluting stent in about 270 patients with...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >